Calcium and vitamin D supplementation and risk of kidney stone formation in postmenopausal women

Iranian Journal of Kidney Diseases

Volumn 7, Issue 3, 2013, Pages 210-213

  Haghighi, Anousheh ^a   Samimagham, Hamidreza ^b   Gahardehi, Golnar ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b HORMOZGAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Calcium; Osteoporosis; Postmenopause; Urinary calculi

Indexed keywords

CALCITONIN; CALCIUM; DIURETIC AGENT; VITAMIN D;

ADULT; AGED; ARTICLE; BLOOD EXAMINATION; BONE DISEASE; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; METABOLIC DISORDER; METABOLISM; NEPHROLITHIASIS; POSTMENOPAUSE; RENOGRAPHY; RHEUMATIC DISEASE; RHEUMATOLOGY; RISK FACTOR; URINARY EXCRETION;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BONE DENSITY CONSERVATION AGENTS; CALCIUM; DIETARY SUPPLEMENTS; DRUG COMBINATIONS; FEMALE; HUMANS; KIDNEY CALCULI; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; VITAMIN D;

EID: 84878077265     PISSN: 17358582     EISSN: 17358604     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. [No author listed]. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med. 1993;94:646-50.
2. Kanis JA, Brazier JE, Stevenson M, Calvert NW, Lloyd JM. Treatment of established osteoporosis: a systematic review and cost-utility analysis. Health Technol Assess. 2002;6:1-146.
3. Cummings SR, Black DM, Nevitt MC, et al. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet. 1993;341:72-5.
4. Asomaning K, Bertone-Johnson ER, Nasca PC, Hooven F, Pekow PS. The association between body mass index and osteoporosis in patients referred for a bone mineral density examination. J Womens Health (Larchmt). 2006;15:1028-34.
5. Ray NF, Chan JK, Thamer M, Melton LJ, III. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res. 1997;12:24-35.
6. Yu JB, Zhang ZL, Zhang H, et al. The changes of bone mineral density and prevalence of osteoporosis in women from Shanghai city. Chin J Osteoporos. 2008;14:258-62.
7. Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet. 2002;359:1761-7.
8. Heaney RP, Weaver CM. Calcium and vitamin D. Endocrinol Metab Clin North Am. 2003;32:181-viii.
9. Flynn A. The role of dietary calcium in bone health. Proc Nutr Soc. 2003;62:851-8.
10. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001;22:477-501.
11. Rodgers A. Aspects of calcium oxalate crystallization: theory, in vitro studies, and in vivo implementation. J Am Soc Nephrol. 1999;10 Suppl 14:S351-S354.
12. Fallahzadeh MH, Zare J, Al-Hashemi GH, et al. Elevated serum levels of Vitamin D in infants with urolithiasis. Iran J Kidney Dis. 2012;6:186-91.
13. Hess B, Tiselius HG. Physical-chemical processes in kidney stone formation. In: Coe FL, Favus MJ, editors. Disorders of bone and mineral metabolism. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2002. p.619-28.
14. Heaney RP. Calcium supplementation and incident kidney stone risk: a systematic review. J Am Coll Nutr. 2008;27:519-27.
15. Jackson RD, LaCroix AZ, Gass M, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006;354:669-83.
16. Diaz-Lopez B, Cannata-Andia JB. Supplementation of vitamin D and calcium: advantages and risks. Nephrol Dial Transplant. 2006;21:2375-7.
17. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993;328:833-8.
18. Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002;346:77-84.
19. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin d, and fluoride. Washington, DC: National Academy Press; 1996.
20. Chandhoke PS. Metabolic abnormalities and the medical management of calcium oxalate nephrolithiasis. Minerva Urol Nefrol. 2005;57:9-16.
21. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003;63:1817-23.
22. Dawson-Hughes B, Dallal GE, Krall EA, Sadowski L, Sahyoun N, Tannenbaum S. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med. 1990;323:878-83.
23. Cumming RG. Calcium intake and bone mass: a quantitative review of the evidence. Calcif Tissue Int. 1990;47:194-201.
24. Heaney RP. Effect of calcium on skeletal development, bone loss, and risk of fractures. Am J Med. 1991;91:23S-8S.
25. Avioli LV, Heaney RP. Calcium intake and bone health. Calcif Tissue Int. 1991;48:221-3.
26. [No author listed]. Consensus conference: Osteoporosis. JAMA. 1984;252:799-802.